Afrocentric Investment (JSE:ACT) 3-Year EBITDA Growth Rate : -6.20% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Afrocentric Investment 3-Year EBITDA Growth Rate?

Afrocentric Investment's EBITDA per Share for the six months ended in Dec. 2023 was R0.52.

During the past 12 months, Afrocentric Investment's average EBITDA Per Share Growth Rate was -34.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -6.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 9.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Afrocentric Investment was 85.70% per year. The lowest was -6.20% per year. And the median was 12.15% per year.

Competitive Comparison of Afrocentric Investment's 3-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Afrocentric Investment's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Afrocentric Investment's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Afrocentric Investment's 3-Year EBITDA Growth Rate falls into.

Afrocentric Investment 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Afrocentric Investment (JSE:ACT) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Afrocentric Investment 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Afrocentric Investment's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Afrocentric Investment (JSE:ACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Afrocentric Investment Corp Ltd (JSE:ACT) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

37 Conrad Road, Florida North, Roodepoort, ZAF, 1709

Website

http://www.afrocentric.za.com

Afrocentric Investment Corp Ltd is a black-owned investment holding company with an investment portfolio focused on services to the healthcare sector. It seeks to invest in healthcare-related businesses that demonstrate prospects for growth as well as diversify its revenue sources while contributing to the sustainable health and welfare of South African communities. The company provides health administration and health risk management solutions to the healthcare industry. It also provides a range of complementary services to its traditional medical scheme clients and a portfolio of healthcare-related enterprises. These services include information technology solutions, transactional switching, specialized disease management, pharmaceutical wholesaling, amongst others.